Guidant v. Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
California federal court grants motions for summary judgment in Guidant Advanced Cardiovascular Systems' suit alleging infringement of ACS patents by Boston Scientific Scimed's Bandit angioplasty catheter. While the court granted a motion "asserting the validity and infringement" of the ACS patent, it denied a motion for summary judgment on the "enforceability" of the ACS patent, as well as Scimed's motions for "summary judgment asserting the invalidity of, and Scimed's failure to willfully infringe, ACS's patent," Boston Scientific says. Trial on the remaining issues is expected in February 2000. Boston Scientific maintains that it will appeal the court's order and that an "adverse outcome is not probable." Bandit sales were $45 mil. in 1998 and "insignificant" in 1999, the firm says
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.